Baidu
map

风湿免疫科指南

订阅

MedSci主页 / 所有栏目 / 风湿免疫科指南

2019 AASLD实践指南：成人和儿童自身免疫性肝炎的诊断和治疗

2019-12-21 美国肝病研究学会 Hepatology. 2019 Dec 21.

自身免疫性肝炎

2019年12月，美国肝病研究学会(AASLD)发布了成人和儿童自身免疫性肝炎的诊断和治疗指南，本文是对2010年AASLD自身免疫性肝炎指南的更新，主要基于当前证据以及专家观点等针对成人和儿童自身免疫性肝炎的诊断和治疗提出指导建议。

中文标题：

2019 AASLD实践指南：成人和儿童自身免疫性肝炎的诊断和治疗

英文标题：

Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the study of liver diseases.

发布机构：

美国肝病研究学会

发布日期：

2019-12-21

简要介绍：

2019年12月，美国肝病研究学会(AASLD)发布了成人和儿童自身免疫性肝炎的诊断和治疗指南，本文是对2010年AASLD自身免疫性肝炎指南的更新，主要基于当前证据以及专家观点等针对成人和儿童自身免疫性肝炎的诊断和治疗提出指导建议。

 

拓展指南：与肝炎相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2019 AASLD实践指南：成人和儿童自身免疫性肝炎的诊断和治疗)] GetToolGuiderByIdResponse(projectId=1, id=f8ae01c0018a45fd, title=2019 AASLD实践指南：成人和儿童自身免疫性肝炎的诊断和治疗, enTitle=Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the study of liver diseases., guiderFrom=Hepatology. 2019 Dec 21., authorId=null, author=, summary=2019年12月，美国肝病研究学会(AASLD)发布了成人和儿童自身免疫性肝炎的诊断和治疗指南，本文是对2010年AASLD自身免疫性肝炎指南的更新，主要基于当前证据以及专家观点等针对成人和儿童自身免疫性肝炎的诊断和治疗提出指导建议。 , cover=, journalId=null, articlesId=null, associationId=65, associationName=美国肝病研究学会, associationIntro=美国肝病学会于1950年3月在伊利诺斯州美国肝病学会正式成立。目前已经拥有2,700多名的专家会员和研究员，成为致力于肝病研究和学术交流最为重要的国际性学术组织。 该学会除了每年11月左右举行的一年一度的年会外，还联合美国胃肠病协会（AGA， American Gastroenterological Association ）、美国胃肠内镜学会（ASGE ， American Society for Gastrointestinal Endoscopy） 和消化外科学会（SSAT， Society for Surgery of the Alimentary Tract）每年举行一次&ldquo;消化疾病周&rdquo;学术交流会。该学会拥有HEPATOLOGY和Liver Transplantation两本影响力非常大的专业杂志。, copyright=0, guiderPublishedTime=Sat Dec 21 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>2019年12月，美国肝病研究学会(AASLD)发布了成人和儿童自身免疫性肝炎的诊断和治疗指南，本文是对2010年AASLD自身免疫性肝炎指南的更新，主要基于当前证据以及专家观点等针对成人和儿童自身免疫性肝炎的诊断和治疗提出指导建议。 </P> <P> </P>拓展指南：<strong>与<font color=red>肝炎</font>相关指南：</strong><br><ul><li><a href="//www.sandwebs.com/guideline/show_article.do?id=8b3641c0018a1683" title="丙型肝炎防治指南（2019年版）" target=_blank>丙型肝炎防治指南（2019年版）</a></li> <li><a href="//www.sandwebs.com/guideline/show_article.do?id=e330b1c001833558" title="2019 SIA意见书：晚期酒精性肝病和重症急性酒精性肝炎的管理" target=_blank>2019 SIA意见书：晚期酒精性肝病和重症急性酒精性肝炎的管理</a></li> <li><a href="//www.sandwebs.com/guideline/show_article.do?id=239d91c001821adb" title="乙型肝炎病毒耐药相关基因突变检测试剂技术审查指导原则（征求意见稿）" target=_blank>乙型肝炎病毒耐药相关基因突变检测试剂技术审查指导原则（征求意见稿）</a></li> <li><a href="//www.sandwebs.com/guideline/show_article.do?id=fd2ee1c00181ae5b" title="慢性乙型肝炎抗病毒治疗药物临床试验技术指导原则" target=_blank>慢性乙型肝炎抗病毒治疗药物临床试验技术指导原则</a></li> <li><a href="//www.sandwebs.com/guideline/show_article.do?id=8689d1c001810a9a" title="中国乙型肝炎病毒母婴传播防治指南（2019年版）" target=_blank>中国乙型肝炎病毒母婴传播防治指南（2019年版）</a></li> 更多信息请点击：<a href="//www.sandwebs.com/guideline/list.do?q=%E8%82%9D%E7%82%8E" target=_blank>有关肝炎更多指南</a></ul>, tagList=[TagDto(tagId=1265, tagName=自身免疫性肝炎)], categoryList=[CategoryDto(categoryId=15, categoryName=风湿免疫科, tenant=100), CategoryDto(categoryId=22, categoryName=肝病, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8126, appHits=389, showAppHits=23, pcHits=4923, showPcHits=4055, likes=62, shares=18, comments=9, approvalStatus=1, publishedTime=Thu Dec 26 23:59:36 CST 2019, publishedTimeString=2019-12-21, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Thu Dec 26 23:59:36 CST 2019, updatedBy=null, updatedName=null, updatedTime=Tue Jan 02 11:25:49 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 AASLD实践指南：成人和儿童自身免疫性肝炎的诊断和治疗)])
2019 AASLD实践指南：成人和儿童自身免疫性肝炎的诊断和治疗
下载请点击：
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1065312, encodeId=2fb8106531260, content=真好，及时更新指南，棒棒哒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65a12640266, createdName=512211085, createdTime=Sat Oct 30 16:48:28 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970658, encodeId=ae709e0658e3, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210102/67ea0cb7eff14eb9a435e94ada3c18e4/b0b4df1e288d4924bd52e5dd58fe7e16.jpg, createdBy=d2265449024, createdName=DR.changle, createdTime=Thu Jun 03 19:02:50 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886082, encodeId=7ba48860821a, content=临床很实用，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=875f5410884, createdName=ms4000001186468874, createdTime=Thu Sep 17 16:05:35 CST 2020, time=2020-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805399, encodeId=45618053995c, content=不错不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f80c5403752, createdName=李冉颜, createdTime=Fri Jul 31 15:59:24 CST 2020, time=2020-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805263, encodeId=de218052633b, content=这么快又出新指南了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63d35403765, createdName=ms9000001918915257, createdTime=Thu Jul 30 22:49:20 CST 2020, time=2020-07-30, status=1, ipAttribution=)]
    2021-10-30 512211085

    真好，及时更新指南，棒棒哒

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1065312, encodeId=2fb8106531260, content=真好，及时更新指南，棒棒哒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65a12640266, createdName=512211085, createdTime=Sat Oct 30 16:48:28 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970658, encodeId=ae709e0658e3, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210102/67ea0cb7eff14eb9a435e94ada3c18e4/b0b4df1e288d4924bd52e5dd58fe7e16.jpg, createdBy=d2265449024, createdName=DR.changle, createdTime=Thu Jun 03 19:02:50 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886082, encodeId=7ba48860821a, content=临床很实用，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=875f5410884, createdName=ms4000001186468874, createdTime=Thu Sep 17 16:05:35 CST 2020, time=2020-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805399, encodeId=45618053995c, content=不错不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f80c5403752, createdName=李冉颜, createdTime=Fri Jul 31 15:59:24 CST 2020, time=2020-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805263, encodeId=de218052633b, content=这么快又出新指南了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63d35403765, createdName=ms9000001918915257, createdTime=Thu Jul 30 22:49:20 CST 2020, time=2020-07-30, status=1, ipAttribution=)]
    2021-06-03 DR.changle

    赞

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1065312, encodeId=2fb8106531260, content=真好，及时更新指南，棒棒哒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65a12640266, createdName=512211085, createdTime=Sat Oct 30 16:48:28 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970658, encodeId=ae709e0658e3, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210102/67ea0cb7eff14eb9a435e94ada3c18e4/b0b4df1e288d4924bd52e5dd58fe7e16.jpg, createdBy=d2265449024, createdName=DR.changle, createdTime=Thu Jun 03 19:02:50 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886082, encodeId=7ba48860821a, content=临床很实用，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=875f5410884, createdName=ms4000001186468874, createdTime=Thu Sep 17 16:05:35 CST 2020, time=2020-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805399, encodeId=45618053995c, content=不错不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f80c5403752, createdName=李冉颜, createdTime=Fri Jul 31 15:59:24 CST 2020, time=2020-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805263, encodeId=de218052633b, content=这么快又出新指南了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63d35403765, createdName=ms9000001918915257, createdTime=Thu Jul 30 22:49:20 CST 2020, time=2020-07-30, status=1, ipAttribution=)]
    2020-09-17 ms4000001186468874

    临床很实用，谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1065312, encodeId=2fb8106531260, content=真好，及时更新指南，棒棒哒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65a12640266, createdName=512211085, createdTime=Sat Oct 30 16:48:28 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970658, encodeId=ae709e0658e3, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210102/67ea0cb7eff14eb9a435e94ada3c18e4/b0b4df1e288d4924bd52e5dd58fe7e16.jpg, createdBy=d2265449024, createdName=DR.changle, createdTime=Thu Jun 03 19:02:50 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886082, encodeId=7ba48860821a, content=临床很实用，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=875f5410884, createdName=ms4000001186468874, createdTime=Thu Sep 17 16:05:35 CST 2020, time=2020-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805399, encodeId=45618053995c, content=不错不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f80c5403752, createdName=李冉颜, createdTime=Fri Jul 31 15:59:24 CST 2020, time=2020-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805263, encodeId=de218052633b, content=这么快又出新指南了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63d35403765, createdName=ms9000001918915257, createdTime=Thu Jul 30 22:49:20 CST 2020, time=2020-07-30, status=1, ipAttribution=)]
    2020-07-31 李冉颜

    不错不错

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1065312, encodeId=2fb8106531260, content=真好，及时更新指南，棒棒哒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=65a12640266, createdName=512211085, createdTime=Sat Oct 30 16:48:28 CST 2021, time=2021-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970658, encodeId=ae709e0658e3, content=赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210102/67ea0cb7eff14eb9a435e94ada3c18e4/b0b4df1e288d4924bd52e5dd58fe7e16.jpg, createdBy=d2265449024, createdName=DR.changle, createdTime=Thu Jun 03 19:02:50 CST 2021, time=2021-06-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=886082, encodeId=7ba48860821a, content=临床很实用，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=875f5410884, createdName=ms4000001186468874, createdTime=Thu Sep 17 16:05:35 CST 2020, time=2020-09-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805399, encodeId=45618053995c, content=不错不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=152, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f80c5403752, createdName=李冉颜, createdTime=Fri Jul 31 15:59:24 CST 2020, time=2020-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=805263, encodeId=de218052633b, content=这么快又出新指南了，谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=160, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63d35403765, createdName=ms9000001918915257, createdTime=Thu Jul 30 22:49:20 CST 2020, time=2020-07-30, status=1, ipAttribution=)]
    2020-07-30 ms9000001918915257

    这么快又出新指南了，谢谢分享

    0

相关指南

2015 自身免疫性肝炎诊断和治疗共识

中华医学会肝病学分会(Chinese Society of Hepatology, CMA) · 2015-10-25

Baidu
map
Baidu
map
Baidu
map